XML 15 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Changes in Shareholders’ Equity (Unaudited) - USD ($)
Common Stock
Additional paid-in capital
Accumulated deficits
Accumulated other comprehensive income (loss)
Total
Balance at Mar. 31, 2023 $ 913,785 $ 35,588,214 $ (21,613,133) $ (197,571) $ 14,691,295
Balance (in Shares) at Mar. 31, 2023 [1] 457,365        
Net loss (9,696,158) (9,696,158)
Shares issued for convertible notes $ 540,971 361,467 902,438
Shares issued for convertible notes (in Shares) [1] 270,486        
Foreign currency translation gain (821,240) (821,240)
Balance at Sep. 30, 2023 $ 1,454,756 35,949,681 (31,309,291) (1,018,811) 5,076,335
Balance (in Shares) at Sep. 30, 2023 [1] 727,851        
Balance at Mar. 31, 2024 $ 4,352,290 35,315,616 (24,711,665) (1,025,795) 13,930,446
Balance (in Shares) at Mar. 31, 2024 [1] 2,218,206        
Net loss (802,568) (802,568)
Shares issued for convertible notes $ 3,376,530 (1,926,394) 1,450,136
Shares issued for convertible notes (in Shares) [1] 1,688,265        
Foreign currency translation gain 456,943 456,943
Balance at Sep. 30, 2024 $ 7,728,820 $ 33,389,222 $ (25,514,233) $ (568,853) $ 15,034,956
Balance (in Shares) at Sep. 30, 2024 [1] 3,906,471        
[1] Retrospectively restated for effect of reverse stock split on February 22, 2021, May 19, 2022 and October 5, 2023.